Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000719

Drug Information
NamePhentermine    
Synonymsalpha.,.alpha.-dimethyl-Benzeneethanamine; Phentermine HCl; Phentrol; Lipopill; MolPort-002-043-208; RCRA waste no. P046; CHEMBL1574; Ortetaminum; Phentercot; 2-methyl-1-phenylpropan-2-amine; UNII-VF4N11KKKR; Obermine; Adipex-P; Omnibex; AC1L1IX2; C07438; 9008-94-0; alpha,alpha-Dimethylphenethylamine; Normephentermine; Ortetamine [INN]; 35373-71-8; Phenterminum [INN-Latin]; Phenethylamine, alpha,alpha-dimethyl-; D05458; Phenyl-tertiary-butylamine; Fastin; Ionamine; 122-09-8; EINECS 204-522-1; 1,1-Dimethyl-2-phenylethylamine; BRN 0970319; HSDB 3158; Ortetamina; Ionamin; Phenterminum; Phentrol 3; 1-(2-Tolyl)-2-propylamine; Phentermine resin complex; DEA No. 1640; Lonamin; Wilpo; Duromine; 1197-21-3 (hydrochloride); CID4771; AmbkkkkK744; Pro-Fast; HMS2093B16; alpha-Benzylisopropylamine; Obenix; 2-Methyl-1-phenyl-2-propanamine; 2-Propylamine, 1-(2-methylphenyl)-; (alpha,alpha)-Dimethylphenethylamine; LS-103327; Phenyl-tert-butylamine; Fentermina; Phenethylamine, .alpha.,.alpha.-dimethyl-; Linyl; Ona Mast; Ortetamin; Ethanamine, 1,1-dimethyl-2-phenyl-; Phentermine [USAN:INN:BAN]; 2-Phenyl-tert-butylamine; Phentride; Benzeneethanamine, .alpha.,.alpha.-dimethyl-; AKOS004123261; Zantryl; CHEBI:8080; InChI=1/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H; Phentrol 2; phentermine; Benzeneethanamine, alpha,alpha-dimethyl-; alpha,alpha-Dimethylbenzeneethanamine; 2-Amino-2-methyl-1-phenylpropane; 12674-13-4; UNII-C045TQL4WP; Phentermine Resin 30; alpha,alpha-Dimethyl-beta-phenylethylamine; Phentermine (USAN/INN); Mirapront; RCRA waste number P046; Phentrol 4; 1-(2-Methylphenyl)-2-propylamin; Inoamin; DB00191; Fentermina [INN-Spanish]; Oby-Trim    
Trade NameAdipex P; Anoxine-AM; Ionamin; Duromine; Fastin; Mirapront; Obephen; Obermine; Obestin-30; Phentremene; Phentrol; Phenterex; Phentromin; Pro-Fast SA; Redusa; Panbesy; Phentermine Trenker; Obenix; Oby-Trim; Teramine; Zantryl; Sinpet; Supremin; Umine; Weltmine    
CompanyMedeva Pharmaceuticals    
IndicationObesityApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAppetite Depressants    
CAS NumberCAS 122-09-8
FormularC10H15N    
PubChem Compound IDCID 4771.    
PubChem Substance IDSID 9642.    
ChEBI8080;    
SuperDrug ATC IDC01CA11;    
SuperDrug CAS ID000100925;    
TargetNoradrenergic re-uptakeInhibitor[2]
Ref 1Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. To Reference
Ref 2Novel anti-obesity drugs. Expert Opin Investig Drugs. 2000 Jun;9(6):1317-26. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543